View in EDS

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.

Saved in:
Bibliographic Details
Title: 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Authors: Pivot, Xavier1 xavier.pivot@univ-fcomte.fr, Romieu, Gilles2, Debled, Marc3, Pierga, Jean-Yves4, Kerbrat, Pierre5, Bachelot, Thomas6, Lortholary, Alain7, Espié, Marc8, Fumoleau, Pierre9, Serin, Daniel10, Jacquin, Jean-Philippe11, Jouannaud, Christelle12, Rios, Maria13, Abadie-Lacourtoisie, Sophie14, Tubiana-Mathieu, Nicole15, Cany, Laurent16, Catala, Stéphanie17, Khayat, David18, Pauporté, Iris19, Kramar, Andrew20
Source: Lancet Oncology. Jul2013, Vol. 14 Issue 8, p741-748. 8p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 89137173
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Pivot%2C+Xavier%22">Pivot, Xavier</searchLink><relatesTo>1</relatesTo><i> xavier.pivot@univ-fcomte.fr</i><br /><searchLink fieldCode="AR" term="%22Romieu%2C+Gilles%22">Romieu, Gilles</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Debled%2C+Marc%22">Debled, Marc</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Pierga%2C+Jean-Yves%22">Pierga, Jean-Yves</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Kerbrat%2C+Pierre%22">Kerbrat, Pierre</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Bachelot%2C+Thomas%22">Bachelot, Thomas</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Lortholary%2C+Alain%22">Lortholary, Alain</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Espié%2C+Marc%22">Espié, Marc</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Fumoleau%2C+Pierre%22">Fumoleau, Pierre</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Serin%2C+Daniel%22">Serin, Daniel</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Jacquin%2C+Jean-Philippe%22">Jacquin, Jean-Philippe</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Jouannaud%2C+Christelle%22">Jouannaud, Christelle</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Rios%2C+Maria%22">Rios, Maria</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Abadie-Lacourtoisie%2C+Sophie%22">Abadie-Lacourtoisie, Sophie</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Tubiana-Mathieu%2C+Nicole%22">Tubiana-Mathieu, Nicole</searchLink><relatesTo>15</relatesTo><br /><searchLink fieldCode="AR" term="%22Cany%2C+Laurent%22">Cany, Laurent</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Catala%2C+Stéphanie%22">Catala, Stéphanie</searchLink><relatesTo>17</relatesTo><br /><searchLink fieldCode="AR" term="%22Khayat%2C+David%22">Khayat, David</searchLink><relatesTo>18</relatesTo><br /><searchLink fieldCode="AR" term="%22Pauporté%2C+Iris%22">Pauporté, Iris</searchLink><relatesTo>19</relatesTo><br /><searchLink fieldCode="AR" term="%22Kramar%2C+Andrew%22">Kramar, Andrew</searchLink><relatesTo>20</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Jul2013, Vol. 14 Issue 8, p741-748. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=89137173
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(13)70225-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 741
    Titles:
      – TitleFull: 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pivot, Xavier
      – PersonEntity:
          Name:
            NameFull: Romieu, Gilles
      – PersonEntity:
          Name:
            NameFull: Debled, Marc
      – PersonEntity:
          Name:
            NameFull: Pierga, Jean-Yves
      – PersonEntity:
          Name:
            NameFull: Kerbrat, Pierre
      – PersonEntity:
          Name:
            NameFull: Bachelot, Thomas
      – PersonEntity:
          Name:
            NameFull: Lortholary, Alain
      – PersonEntity:
          Name:
            NameFull: Espié, Marc
      – PersonEntity:
          Name:
            NameFull: Fumoleau, Pierre
      – PersonEntity:
          Name:
            NameFull: Serin, Daniel
      – PersonEntity:
          Name:
            NameFull: Jacquin, Jean-Philippe
      – PersonEntity:
          Name:
            NameFull: Jouannaud, Christelle
      – PersonEntity:
          Name:
            NameFull: Rios, Maria
      – PersonEntity:
          Name:
            NameFull: Abadie-Lacourtoisie, Sophie
      – PersonEntity:
          Name:
            NameFull: Tubiana-Mathieu, Nicole
      – PersonEntity:
          Name:
            NameFull: Cany, Laurent
      – PersonEntity:
          Name:
            NameFull: Catala, Stéphanie
      – PersonEntity:
          Name:
            NameFull: Khayat, David
      – PersonEntity:
          Name:
            NameFull: Pauporté, Iris
      – PersonEntity:
          Name:
            NameFull: Kramar, Andrew
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2013
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1